DaVita Healthcare Partners | DVA


EPS Reference Time Actual Consensus Previous
2026-10-23 FY2026Q3 PM 3.93 2.51
2026-08-05 FY2026Q2 PM 3.84 2.95
2026-05-05 FY2026Q1 PM 2.87 2.34 2.00
2026-02-02 FY2025Q4 PM 3.40 3.29 2.24
2025-10-29 FY2025Q3 PM 2.51 3.22 2.59



Peers Price Chg Day Year Date
Acadia Healthcare 35.16 0.73 2.12% 60.40% Jul/21
Addus HomeCare 111.19 -0.31 -0.28% 3.53% Jul/21
Elevance Health 386.70 4.47 1.17% 37.26% Jul/21
HeartBeam 0.57 0.002 0.35% -55.12% Jul/21
Option Care Health 21.61 -0.14 -0.64% -27.43% Jul/21
Brookdale Senior Living 14.94 0.01 0.03% 95.48% Jul/21
Cardinal Health 226.91 1.16 0.51% 44.44% Jul/21
Concord Medical Services Hldg 4.03 -0.01 -0.25% -29.79% Jul/21
Cross Country Healthcare 13.25 0.01 0.08% -0.82% Jul/20
Chemed 504.41 -9.27 -1.80% 11.38% Jul/21

Indexes Price Day Year Date
US500 7503 65.92 0.89% 17.99% Jul/22

DaVita Healthcare Partners traded at $236.10 this Tuesday July 21st, increasing $2.00 or 0.85 percent since the previous trading session. Looking back, over the last four weeks, DaVita Healthcare Partners gained 12.60 percent. Over the last 12 months, its price rose by 61.66 percent. Looking ahead, we forecast DaVita Healthcare Partners to be priced at 230.13 by the end of this quarter and at 215.94 in one year, according to Trading Economics global macro models projections and analysts expectations.

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.